03:45 PM Abstract No. 330 Assessing outcomes of Yttrium-90 radioembolization for biphenotypic hepatocellular-cholangiocarcinoma

Biphenotypic hepatocellular-cholangiocarcinoma (HCC-CC) is a rare type of primary liver cancer that carries a poor prognosis. Since most patients present at a stage too advanced for surgical resection, loco-regional liver directed therapy is often performed for palliative or downstaging purposes. The purpose of this study is to evaluate patient outcomes after Yttrium-90 radioembolization (Y90) in patients with HCC-CC.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 34: Y-90 Y Not (Radioembolization II) Source Type: research